ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models. - Zhang L; Castanaro C; Luan B; Yang K; Fan L; Fairhurst JL; Rafique A; Potocky TB; Shan J; Delfino FJ; Shi E; Huang T; et al. (Molecular cancer therapeutics, 2014)